IRS2 and glioblastoma: The first paper to functionally characterize miR-7 in GBM was published in 2008 by Kefas et al. and utilized a luciferase reporter assay to establish EGFR, frequently amplified in GBM [66], and IRS-2 as a direct targets of miR-7 [65].